Bicarbonate

Bicarbonate

SCHEMBL2836236

O=C(O)O.OCC(O)c1ccccc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
KDM4E B2RXH2 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
BCAT2 O15382 1/20 0.52
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
AOC3 Q16853 4/20 0.48
CYP2D6 P10635 1/20 0.46
SRC P12931 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
RIPK1 Q13546 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413766 0.93 LMNA (0.61) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL1947849 0.93 LMNA (0.61) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL8366350 0.93 LMNA (0.61) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL24750 0.93 LMNA (0.61) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL30957022 0.93 LMNA (0.61) LMNAKDM4EL3MBTL1BCAT2NPC1
Carbamic Acid SCHEMBL3394720 0.91 BCAT2 (0.58) LMNAKDM4EL3MBTL1BCAT2NPC1
Carbamic Acid SCHEMBL6362690 0.91 BCAT2 (0.58) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL29588786 0.90 LMNA (0.58) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL18813398 0.90 LMNA (0.58) LMNAKDM4EL3MBTL1BCAT2NPC1
SCHEMBL27887405 0.90 LMNA (0.58) LMNAKDM4EL3MBTL1BCAT2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4082729-A PROCESS FOR THE PREPARATION OF OXYMETHYLENE POLYMERS HOECHST AKTIENGESELLSCHAFT (DT) 1978-04-04 US claimed
CN-111246873-B Optimized peptides for targeting human nerves and their use in image guided surgery, diagnosis and therapy delivery 加利福尼亚大学董事会 2024-03-01 CN disclosed
EP-2248799-B1 PROCESS FOR PREPARING 2-(SUBSTITUTED PHENYL)-2-HYDROXY-ETHYL CARBAMATES SK BIOPHARMACEUTICALS CO LTD (KR) 2015-05-20 EP disclosed
EP-2248799-A1 Process for preparing 2-(substituted phenyl)-2-hydroxy-ethyl carbamates Ortho-McNeil Pharmaceutical, Inc. (US) 2010-11-10 EP disclosed
US-20080097077-A1 Method For Producing Polyoxymethylenes BASF AKTIENGESELLSCHAFT (DE) 2008-04-24 US disclosed
EP-1461309-A1 PROCESS FOR PREPARING 2-(SUBSTITUTED PHENYL) - 2 - HYDROXY-ETHYL CARBAMATES Ortho-McNeil Pharmaceutical, Inc. (US) 2004-09-29 EP disclosed
WO-2003053916-A1 PROCESS FOR PREPARING 2-(SUBSTITUTED PHENYL) - 2 - HYDROXY-ETHYL CARBAMATES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-07-03 WO disclosed
US-4082729-A PROCESS FOR THE PREPARATION OF OXYMETHYLENE POLYMERS HOECHST AKTIENGESELLSCHAFT (DT) 1978-04-04 US disclosed